Image source: Getty Images.
You can almost count the number of biotech stocks that pay out dividends on one hand.But while the quantity might be low, the quality isn't (at least for the most part). Here are a couple of biotech dividend stocks that appear to be in great shape to raise their dividends -- and one that isn't.
Gilead Sciences (NASDAQ:GILD) ruled the HIV therapy market for years. The big biotech still maintains a dominant position with its HIV franchise, but these days Gilead is known even more for its hugely successful hepatiti